Latest Ratings for GILD
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Barclays | Maintains | Underweight | |
| Mar 2022 | RBC Capital | Maintains | Outperform | |
| Feb 2022 | BMO Capital | Downgrades | Outperform | Market Perform |
Breaking Down Gilead Sciences: 22 Analysts Share Their Views
Where Today's News Shapes Tomorrow
